# Drug Use Investigation of Gadovist.

> **NCT02540967** · — · COMPLETED · sponsor: **Bayer** · enrollment: 3357 (actual)

## Conditions studied

- Magnetic Resonance Imaging
- Image Enhancement

## Interventions

- **DRUG:** Gadobutrol (Gadavist/Gadovist, BAY86-4875)

## Key facts

- **NCT ID:** NCT02540967
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-27
- **Primary completion:** 2017-11-02
- **Final completion:** 2017-11-02
- **Target enrollment:** 3357 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02540967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02540967, "Drug Use Investigation of Gadovist.". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02540967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*